458 results on '"Tyldesley S"'
Search Results
2. Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial
3. In the Era After the European Organisation for Research and Treatment of Cancer ‘Boost’ Study, is the Additional Radiotherapy to the Breast Tumour Bed Still Beneficial for Young Women?
4. Pathologically Node-Positive Prostate Carcinoma – Prevalence, Pattern of Care and Outcome From a Population-Based Study
5. Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial
6. Polymetastatic Recurrence-Free Survival in Patients with Repeat Oligometastases on the SABR-5 Trial
7. The Relationship between Hot Flashes and Testosterone Recovery after 12 Months of Androgen Suppression for Men with Localised Prostate Cancer in the ASCENDE-RT Trial
8. OC-0268 Should OARs be prioritized in SABR for oligometastases? A secondary analysis of the SABR-5 trial
9. Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast
10. Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial
11. Impact of Quality Assurance and Feedback on Radiotherapy Prescribing Practices: A Randomized Controlled Trial
12. First Pan-Canadian Consensus Recommendations for Proton Beam Therapy Access in Canada
13. Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial
14. A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy
15. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
16. Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome
17. PO-1031 Canadian Radiation Oncology 2020 Work Engagement and Burnout Survey
18. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
19. Utilisation of Radiotherapy in Rural and Urban Areas in British Columbia Compared with Evidence-based Estimates of Radiotherapy Needs for Patients with Breast, Prostate and Lung Cancer
20. Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for up to 5 Oligometastases: Preliminary Results of the SABR-5 Trial
21. Three-year physician visits among breast cancer survivors in British Columbia, Canada: Abstract O-13
22. General practitioner assessment of stage and performance status in lung cancer patients at a population level: Implications for prognosis and radiotherapy needs analyses
23. Presenting Stage and Risk Group in Men Dying of Prostate Cancer
24. PO-1205: Small cell carcinoma of the bladder: Retrospective long-term outcomes of chemoradiation
25. Stereotactic Ablative Radiotherapy (SABR) For Oligometastases: Risk Stratification Using Positional Uncertainty
26. An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
27. A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
28. THE EFFECT OF SMOKING ON OUTCOME FOLLOWING EXTERNAL RADIATION FOR LOCALIZED PROSTATE CANCER
29. Time Spent in Hospital in the Last Six Months of Life in Patients Who Died of Cancer in Ontario
30. Factors Affecting the Use of Palliative Radiotherapy in Ontario
31. The Appropriate Rate of Breast Conserving Surgery: an Evidence-based Estimate
32. EP-1616 Population-based Phase II Trial of Stereotactic Radiotherapy for up to 5 Oligometastases: SABR-5
33. Evaluating A Multidisciplinary Cancer Conference Checklist: Practice Versus Perceptions
34. Cancer-Specific Outcomes of Hypofractionated Locoregional Radiation Therapy for Patients with Stage I-III Breast Cancer
35. Impact of the Spinal Instability Neoplastic Score on Surgical Referral Patterns and Outcomes
36. The Use of Chemotherapy Instead of Radiation Therapy Does Not Reduce the Incidence of Second Cancers in Survivors of Early Stage Seminoma: A Population-Based Study from British Columbia
37. Mapping Patterns of Regional Nodal Recurrence After Treatment in Breast Cancer Patients: Evaluation of the RTOG Breast Cancer Atlas
38. Neoadjuvant Systemic Therapy in Breast Cancer: Use and Trends in Radiotherapy Practice
39. EP-1195: Regional nodal recurrences after adjuvant breast radiotherapy - are we covering the target?
40. EP-1359: Pain response in a Population-based study of Radium-223 for Metastatic Prostate Cancer
41. Abstract P1-11-01: The effect of close and positive surgical margins on 10-year local recurrence and survival outcomes in women treated with breast conserving surgery plus adjuvant radiotherapy
42. An Evaluation Of Competing Causes Of Death in Patients Treated for Seminoma With Radiation Therapy.
43. Do Young Women Benefit From a Radiation Therapy Boost to the Tumor Bed in the Hormone Therapy Era?
44. Impact of Internal Mammary Node Radiation on Survival of Patients With Breast Cancer: Extended Follow-Up of a Population-Based Analysis
45. The Relationship Between Hot Flashes and Testosterone Recovery Following 12 Months of Androgen Suppression for Men With Localized Prostate Cancer in a Randomized Trial
46. Do Women Who Died of Cardiac Disease Within 10 Years of Breast or Chest Wall Radiation Therapy Violate the “QUANTEC” Cardiac Dose-Volume Histogram Guidelines?
47. Abstract P5-12-10: Comparison of the efficacy of tamoxifen and aromatase inhibitors on survival in adjuvant menopausal breast cancer
48. Toxicity Outcomes in ASCENDE-RT: A Multicenter Randomized Trial of Dose-Escalation Trial for Prostate Cancer
49. Low-Dose-Rate Prostate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavorable Risk Prostate Cancer: The Results of the ASCENDE-RT Randomized Control Trial
50. Using Proliferative Markers and Oncotype Dx in Therapeutic Decision-Making for Breast Cancer: The B.C. Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.